Treatment with capreomycin, with special reference to toxic effects.
D000328:Adult; D000368:Aged; D000471:Alkalosis / Q000139:chemically induced; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D000995:Antitubercular Agents / Q000009:adverse effects*; D003404:Creatinine; D005260:Female; D006311:Hearing Disorders / Q000139:chemically induced; D006801:Humans; D006996:Hypocalcemia / Q000139:chemically induced; D007008:Hypokalemia / Q000139:chemically induced; D007674:Kidney Diseases / Q000139:chemically induced; D008274:Magnesium / Q000097:blood; D008297:Male; D008875:Middle Aged; D009584:Nitrogen / Q000378:metabolism; D011507:Proteinuria / Q000139:chemically induced; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*; D014508:Urea / Q000097:blood
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D014508:Urea; D003404:Creatinine; D008274:Magnesium; D009584:Nitrogen